Table 2 NHFS observed in patients with hip fracture and 30-day mortality in a tertiary centre from Sao Paulo, Brazil, 2020–2023, compared with a Cohort in the UK and estimated mortality by each score category for preoperative assessment.
NHFS levels | N (% from the total)—BR | 30-day mortality, N (%)—BR | N (% from the total)—UK29 | 30-day mortality, N (%)—UK29 | p-value BR vs. UK | NHFS estimated 30-day mortality (%)29 | p-value Br observed mortality vs estimated |
|---|---|---|---|---|---|---|---|
0 | 8 (1.60%) | 0 (0.00) | 59 (2.00) | 0 (0.00) | – | 0.70 | < 0.001 |
1 | 24 (4.80%) | 0 (0.00) | 47 (1.00) | 1 (2.30) | 1.00 | 1.10 | 0.151 |
2 | 10 (2.00%) | 0 (0.00) | 32 (1.00) | 0 (0.00) | – | 1.70 | 0.043 |
3 | 59 (11.7%) | 0 (0.00) | 743 (21.0) | 12 (1.60) | 0.67 | 2.70 | 0.636 |
4 | 153 (30.4%) | 8 (5.20) | 990 (27.0) | 43 (4.30) | 0.77 | 4.40 | 0.943 |
5 | 131 (26.0%) | 13 (10.0) | 888 (25.0) | 75 (8.50) | 0.69 | 6.90 | 0.511 |
6 | 77 (15.3%) | 14 (18.2) | 592 (16.0) | 66 (11.2) | 0.10 | 11.0 | 0.301 |
7 | 34 (6.70%) | 8 (23.5) | 219 (6.00) | 35 (16.0) | 0.39 | 16.0 | 0.635 |
8 | 5 (1.00%) | 2 (40.0) | 46 (1.00) | 9 (19.6) | 0.29 | 24.0 | 0.892 |
9 | 2 (0.50%) | 0 (0.00) | 6 (0.03) | 1 (16.7) | 1.00 | 34.0 | 0.670 |
10 | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | – | 45.0 | – |
